Dignity Health and Catholic Health Initiative, two of the nation’s largest nonprofit health systems, launched the Precision Medicine Alliance in 2016. The collaboration created the largest collection of clinical cancer data ever compiled by a single organization.
This is significant because genomic profiling of tumors at this scale, while usually part of the standard-of-care at large academic medical centers, is not in community practice settings, where physicians typically prescribe standard therapies without access to the patient's genomic information.
In this session, Brent Ohman, the alliance’s director of operations, will discuss the program’s success as a clinical support tool, challenges implementing technology, and future plans, which include expanding the use of genomic information to cardiovascular patients, pharmacogenomics, and medication management.
• The importance of data sharing. By sharing data nationally with other health systems and learning from the experiences of prior patients, oncologists are able to make better recommendations today.
• Data completeness is essential. The value of a precision medicine program relies heavily on the quality and completeness of the underlying data.
• Real world evidence is still emerging. Through data-sharing and access to real-world data, clinicians can see the impact of treatment options faster compared to more traditional clinical trial outcomes.